Citation Impact
Citing Papers
Chapter 1 Ginsenosides
2008 Standout
Microbiota in health and diseases
2022 Standout
Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
2012
Proteome analysis during pod, zygotic and somatic embryo maturation of Theobroma cacao
2015
Fibrates and future PPARα agonists in the treatment of cardiovascular disease
2008
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
The PPARα Activator Fenofibrate Slows Down the Progression of the Left Ventricular Dysfunction in Porcine Tachycardia-Induced Cardiomyopathy
2007
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
2013 Standout
A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists
2013
High-Density Lipoprotein (HDL) Transport in the Metabolic Syndrome: Application of a New Model for HDL Particle Kinetics
2006
The Small Molecule Nobiletin Targets the Molecular Oscillator to Enhance Circadian Rhythms and Protect against Metabolic Syndrome
2016 Standout
Metabolic Syndrome: Treatment of Hypertensive Patients
2007
Troglitazone stimulates β-arrestin-dependent cardiomyocyte contractility via the angiotensin II type 1A receptor
2010
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Differential Activation of Nuclear Receptors by Perfluorinated Fatty Acid Analogs and Natural Fatty Acids: A Comparison of Human, Mouse, and Rat Peroxisome Proliferator-Activated Receptor-α, -β, and -γ, Liver X Receptor-β, and Retinoid X Receptor-α
2006
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
2007 Standout
Major Mango Polyphenols and Their Potential Significance to Human Health
2008 Standout
Renin-Angiotensin-Aldosterone System and Progression of Renal Disease
2006
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
2014 Standout
Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics
2014 Standout
WRKY transcription factors
2010 Standout
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
2009
Lipid‐sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome
2011
Peroxisome proliferator-activated receptor-alpha (PPARα): At the crossroads of obesity, diabetes and cardiovascular disease
2009
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Beyond intestinal soap—bile acids in metabolic control
2014
Gut microbiome and health: mechanistic insights
2022 Standout
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
FXR Acetylation Is Normally Dynamically Regulated by p300 and SIRT1 but Constitutively Elevated in Metabolic Disease States
2009
CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity
2009 Standout
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
REV-ERB and ROR nuclear receptors as drug targets
2014
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
PPARα and PPARγ dual agonists for the treatment of type 2 diabetes and the metabolic syndrome
2006
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Hypolipidemic therapy for the metabolic syndrome
2006
Proteasomal degradation of retinoid X receptor α reprograms transcriptional activity of PPARγ in obese mice and humans
2010
Transcriptome analysis during somatic embryogenesis of the tropical monocot Elaeis guineensis: evidence for conserved gene functions in early development
2009
Seed dormancy and the control of germination
2006 Standout
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Discovery and development of selective PPARγ modulators as safe and effective antidiabetic agents
2010
Biodegradation, biodistribution and toxicity of chitosan
2009 Standout
Bile acids as regulatory molecules
2009
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
SSR markers in transcripts of genes linked to post-transcriptional and transcriptional regulatory functions during vegetative and reproductive development of Elaeis guineensis
2012 Standout
Energy Metabolism in the Liver
2014 Standout
Strong coupling between surface plasmon polaritons and emitters: a review
2014 Standout
Human acidic mammalian chitinase as a novel target for anti-asthma drug design using in silico screening
2013 StandoutNobel
The pathogen Moniliophthora perniciosa promotes differential proteomic modulation of cacao genotypes with contrasting resistance to witches´ broom disease
2020 Standout
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
2013 Standout
Biosynthesis and biotechnological production of ginsenosides
2015 Standout
Dyslipidaemia of Obesity, Metabolic Syndrome and Type 2 Diabetes Mellitus: the Case for Residual Risk Reduction After Statin Treatment
2011
A classification system for seed dormancy
2004 Standout
Peroxisome Proliferator–Activated Receptors as Transcriptional Nodal Points and Therapeutic Targets
2007
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Plant chitinases--regulation and function.
2003
Significance of Inducible Defense-related Proteins in Infected Plants
2006 Standout
The Comparative Analysis of Osmotins and Osmotin‐Like PR‐5 Proteins
2003
T-lymphocyte Infiltration in Visceral Adipose Tissue
2008
Bile acids in glucose metabolism in health and disease
2018
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
The Metabolic Syndrome
2008 Standout
Amorfrutins are potent antidiabetic dietary natural products
2012
Isolation of two somatic embryogenesis-related genes from orchardgrass (Dactylis glomerata)
2002
Survey of the 2009 commercial optical biosensor literature
2011
Effects of the Mango Components Mangiferin and Quercetin and the Putative Mangiferin Metabolite Norathyriol on the Transactivation of Peroxisome Proliferator-Activated Receptor Isoforms
2008
Macrophages, Inflammation, and Insulin Resistance
2010 Standout
Functions and regulation of β-1,3-glucanases during seed germination, dormancy release and after-ripening
2003
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
1998 Standout
Farnesoid X Receptor Inhibits the Transcriptional Activity of Carbohydrate Response Element Binding Protein in Human Hepatocytes
2013
Works of Stéphane Helleboid being referenced
Apolipoprotein A-V Modulates Insulin Secretion in Pancreatic β-cells Through its Interaction with Midkine
2009
The Identification of Naturally Occurring Neoruscogenin as a Bioavailable, Potent, and High-Affinity Agonist of the Nuclear Receptor RORα (NR1F1)
2013
Cloning of β-1,3-glucanases expressed during Cichorium somatic embryogenesis
2000
Three major somatic embryogenesis related proteins in Cichorium identified as PR proteins
2000
Regulation of Human ApoA-I by Gemfibrozil and Fenofibrate Through Selective Peroxisome Proliferator-Activated Receptor α Modulation
2004
Phosphorylation of Farnesoid X Receptor by Protein Kinase C Promotes Its Transcriptional Activity
2008
Molecular Characterization of New Selective Peroxisome Proliferator–Activated Receptor γ Modulators With Angiotensin Receptor Blocking Activity
2005